Autopsy report · NCT06139796

Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV

“Study not started as the IMP is re-worked by the manufacturer”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

PENTA Foundation

Sponsor type

University, hospital or other

Conditions

HIV Infections

Interventions

DRV/r FDC (120/20mg)

Participants

0

Sites

5

Countries

Cameroon, Senegal, Uganda, Zimbabwe

Trials that died the same way

• Clearblue Advanced Fertility Monitor Consumer Three Cycle at Home Study
  “Study not started, no longer required” (68% match in meaning)
• An in Vivo Comparison of the Debridement Efficiency of Needle Irrigation Versus Ultrasonic Irrigation
  “Manufacturer changed device so no study will be done; ie it was never started” (65% match in meaning)
• Multiregion BHA in Open Tibia Fractures
  “study never started and is delayed until further notice” (65% match in meaning)
• HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
  “Company stopped development and production of one of the IMP's.” (65% match in meaning)
• Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
  “Study did not receive IRB approval, so did not start” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.